{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:41:00Z","timestamp":1771299660698,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018846","name":"Erik and Susanna Olesen's Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ahj.2024.11.004","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:58:06Z","timestamp":1731693486000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications"],"prefix":"10.1016","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-6588","authenticated-orcid":false,"given":"Navid","family":"Noory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Westin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Fosb\u00f8l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.11.004_bib0001","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaccao.2021.08.009","article-title":"Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis Outcomes Survey","volume":"3","author":"Nativi-Nicolau","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0003","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaccao.2021.05.004","article-title":"Two decades of cardiac amyloidosis: a danish nationwide study","volume":"3","author":"Westin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"16","key":"10.1016\/j.ahj.2024.11.004_bib0004","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"389","key":"10.1016\/j.ahj.2024.11.004_bib0005","doi-asserted-by":"crossref","first-page":"131204","DOI":"10.1016\/j.ijcard.2023.131204","article-title":"Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance","volume":"5","author":"De Michieli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2024.11.004_bib0006","first-page":"415","article-title":"Value of troponin and NT-proBNP to screen for cardiac amyloidosis after carpal tunnel syndrome surgery","author":"Noory","year":"2024","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2024.11.004_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12203","article-title":"Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis","volume":"5","author":"Takashio","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.004_bib0008","first-page":"1","article-title":"Cardiac troponin in patients with light chain and transthyretin Cardiac amyloidosis: JACC: CardioOncology State-of-the-art review","volume":"6","author":"De Michieli","year":"2024","journal-title":"JACC: CardioOncology"},{"issue":"2","key":"10.1016\/j.ahj.2024.11.004_bib0009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ahj.2024.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ahj.2024.11.004_bib0011","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin Amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2024.11.004_bib0012","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10741-021-10210-w","article-title":"ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study","volume":"27","author":"Uddin","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0013","article-title":"Clinical outcomes of percutaneous coronary intervention in amyloidosis, sarcoidosis, and hemochromatosis","volume":"3","author":"Hussain","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"3","key":"10.1016\/j.ahj.2024.11.004_bib0014","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ehf2.14350","article-title":"Health-related quality of life among transthyretin amyloid cardiomyopathy patients","volume":"10","author":"Eldhagen","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.52.2.233","article-title":"Primary cardiac amyloidosis in a young man presenting with angina pectoris","volume":"52","author":"Saltissi","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.ahj.2024.11.004_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/000331970105200407","article-title":"Cardiac amyloidosis presenting as microvascular angina A case report","volume":"52","author":"Ogawa","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.ahj.2024.11.004_bib0017","article-title":"Primary systemic amyloidosis presenting as angina pectoris due to intramyocardial coronary artery involvement: a case report","volume":"16","author":"Yamano","year":"2002","journal-title":"CASE REPORT Heart Vessels"},{"key":"10.1016\/j.ahj.2024.11.004_bib0018","unstructured":"Cantwell R V, Aviles RJ, Bjornsson J, Scott Wright R, Freeman WK, Oh JK, et al. Cardiac amyloidosis presenting with elevations of Cardiac troponin I and angina Pectoris."},{"issue":"9","key":"10.1016\/j.ahj.2024.11.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2004.038984","article-title":"Angina with a normal coronary angiogram caused by amyloidosis","volume":"90","author":"Whitaker","year":"2004","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ahj.2024.11.004_bib0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ihj.2015.08.029","article-title":"Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: case report","volume":"67","author":"George","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ahj.2024.11.004_bib0021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9343(00)00471-X","article-title":"Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis","volume":"109","author":"Mueller","year":"2000","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ahj.2024.11.004_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa325","article-title":"Cardiac amyloidosis mimicking acute coronary syndrome: A case report and literature review","volume":"4","author":"Nguyen","year":"2020","journal-title":"Eur Heart J - Case Reports"},{"issue":"2","key":"10.1016\/j.ahj.2024.11.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238499","article-title":"Cardiac amyloidosis masquerading as acute coronary syndrome","volume":"14","author":"Tew","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.ahj.2024.11.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.repc.2021.02.002","article-title":"Exertional chest pain is sometimes more than just coronary atherosclerosis","volume":"40","author":"Morgado","year":"2021","journal-title":"Revista Portuguesa de Cardiologia"},{"issue":"1","key":"10.1016\/j.ahj.2024.11.004_bib0025","article-title":"Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis","volume":"5","author":"Vervaat","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"3","key":"10.1016\/j.ahj.2024.11.004_bib0026","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12350-019-01644-9","article-title":"Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4070\/kcj.2011.41.4.209","article-title":"A case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy","volume":"41","author":"Kang","year":"2011","journal-title":"Korean Circ J"},{"issue":"1","key":"10.1016\/j.ahj.2024.11.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-023-03140-y","article-title":"Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients","volume":"23","author":"Hassan","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.ahj.2024.11.004_bib0029","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiol.211288","article-title":"Myocardial late contrast enhancement CT in TroponinPositive acute chest pain syndrome","volume":"302","author":"Palmisano","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ahj.2024.11.004_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2024.11.004_bib0031","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.carpath.2006.09.011","article-title":"Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis","volume":"16","author":"Wittich","year":"2007","journal-title":"Cardiovasc Pathol"},{"issue":"11","key":"10.1016\/j.ahj.2024.11.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.06.017","article-title":"Larsonhematology. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis","volume":"118","author":"Neben-Wittich","year":"2005","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ahj.2024.11.004_bib0033","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.3137","article-title":"Myocardial perfusion in cardiac amyloidosis","volume":"26","author":"Chacko","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0034","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.004_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.carrev.2020.09.026","article-title":"Comparison of patterns of coronary artery disease in patients with heart failure by cardiac amyloidosis status","volume":"27","author":"Beyene","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2024.11.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","author":"Fontana","year":"2024","journal-title":"N Engl J Med [Internet]"},{"issue":"18","key":"10.1016\/j.ahj.2024.11.004_bib0037","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2024.11.004_bib0038","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. a position statement of the European society of cardiology working group on myocardial and pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131813","article-title":"Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis","volume":"402","author":"Kang","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2024.11.004_bib0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjcard.2023.07.140","article-title":"Safety and efficacy of traditional heart failure therapies in patients with cardiac amyloidosis and heart failure","volume":"204","author":"Yan","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2024.11.004_bib0041","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/eurheartj\/ehad357","article-title":"Neurohormonal blockade in transthyretin amyloidosis: perhaps one size does not fit all?","volume":"44","author":"Cheng","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2024.11.004_bib0042","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2024.11.004_bib0043","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: A \u201cdiamond\u201d approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T22:32:42Z","timestamp":1733610762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0002870324002965"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.11.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}